Broad-spectrum anti-cancer activity of fused human arginase variants
Investigational New Drugs · 2024-10 · 42 (5) · 531-537
DOI: 10.1007/s10637-024-01466-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigational New Drugs, online erschienen am 20.08.2024. Verfasst von Yenisetti Rajendra Prasad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Mohali, S.A.S. Nagar, 160062, Punjab, In…. Hauptthemen laut MEDLINE: Arginase, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Mohali, S.A.S. Nagar, 160062, Punjab, India.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Mohali, S.A.S. Nagar, 160062, Punjab, India. apande@niper.ac.in.
Zitieren
APA
Prasad, Y. R., Anakha, J., Jawalekar, S. S., & Pande, A. H. (2024). Broad-spectrum anti-cancer activity of fused human arginase variants. Investigational New Drugs, 42(5), 531-537. https://doi.org/10.1007/s10637-024-01466-8
Vancouver
Prasad YR, Anakha J, Jawalekar SS, Pande AH. Broad-spectrum anti-cancer activity of fused human arginase variants. Investigational New Drugs. 2024;42(5):531-537. doi:10.1007/s10637-024-01466-8
BibTeX
@article{Prasad2024,
author = {Prasad, Yenisetti Rajendra and Anakha, J and Jawalekar, Snehal Sainath and Pande, Abhay H},
title = {Broad-spectrum anti-cancer activity of fused human arginase variants},
journal = {Investigational New Drugs},
year = {2024},
volume = {42},
number = {5},
pages = {531--537},
doi = {10.1007/s10637-024-01466-8}
}
EUVIMED